Sponsor:
University of Alabama at Birmingham
Code:
NCT05556928
Conditions
Multiple Myeloma
Amyloidosis
Plasma Cell Leukemia
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Multiple Myeloma
Amyloidosis
Plasma Cell Leukemia
Study ID
NCT05556928
Start date
Jul 21, 2020
Status verified date
Dec, 2025
Completion date
Dec 31, 2027
Anticipated
Primary completion date
Dec 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Enrollment
5000 participants
Anticipated
Primary outcome measure
Central contacts
Locations
Kirklin Clinic of UAB Hospital
Recruiting
Birmingham, Alabama, United States, 35294
Contacts
Sponsor
University of Alabama at Birmingham
Last update posted
Dec 8, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2025-12-08.